Hitting the brakes on autophagy for overcoming acquired resistance in triple negative breast cancer

Villanueva Cardús, Josep; Bellio, Chiara

dc.contributor	Vall d'Hebron Barcelona Hospital Campus
dc.contributor.author	Villanueva Cardús, Josep
dc.contributor.author	Bellio, Chiara
dc.date.accessioned	2021-11-10T11:19:42Z
dc.date.available	2021-11-10T11:19:42Z
dc.date.issued	2020-07
dc.identifier.citation	Bellio C, Villanueva J. Hitting the brakes on autophagy for overcoming acquired resistance in triple negative breast cancer. Ann Transl Med. 2020 Jul;8(14):848.
dc.identifier.issn	2305-5847
dc.identifier.uri	https://hdl.handle.net/11351/6522
dc.description	Triple negative breast cancer; Autophagy; Therapeutic resistance
dc.description.abstract	Comment on: Wang RX, Xu XE, Huang L, et al. eEF2 kinase mediated autophagy as a potential therapeutic target for paclitaxel-resistant triplenegative breast cancer. Ann Transl Med 2019;7:783.
dc.language.iso	eng
dc.publisher	AME Publishing Company
dc.relation.ispartofseries	Annals of Translational Medicine;8(14)
dc.rights	Attribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.uri	http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.source	Scientia
dc.subject	Mama - Càncer - Quimioteràpia
dc.subject	Resistència als medicaments
dc.subject.mesh	Triple Negative Breast Neoplasms
dc.subject.mesh	/drug therapy
dc.subject.mesh	Drug Resistance, Neoplasm
dc.title	Hitting the brakes on autophagy for overcoming acquired resistance in triple negative breast cancer
dc.type	info:eu-repo/semantics/article
dc.identifier.doi	10.21037/atm.2020.04.17
dc.subject.decs	neoplasias de mama triple negativos
dc.subject.decs	/farmacoterapia
dc.subject.decs	resistencia a los antineoplásicos
dc.relation.publishversion	https://doi.org/10.21037/atm.2020.04.17
dc.type.version	info:eu-repo/semantics/publishedVersion
dc.audience	Professionals
dc.contributor.organismes	Institut Català de la Salut
dc.contributor.authoraffiliation	[Bellio C] Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Villanueva J] Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain
dc.identifier.pmid	32793692
dc.identifier.wos	000554493100008
dc.rights.accessrights	info:eu-repo/semantics/openAccess